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Introduction {#s1}
============

Life is based on the continuous synthesis, modification, and degradation of proteins and other macromolecules. These processes are performed by complex biomolecular machines that bind their ligands and transform them into product molecules. Examples are provided by the transcription of DNA by RNA polymerases, the translation of mRNA by ribosomes, or the degradation of proteins by proteasomes. Each of these processes involves several steps: the binding of the ligand molecules, chemical reactions catalyzed at the active sites, as well as specific conformational changes and directed mechanical movements of parts of the molecular machinery. In principle, the kinetics of such multistep processes can be understood in terms of the individual transitions and the associated transition rates, a well-established approach both for enzyme kinetics [@pcbi.1003909-Michaelis1]--[@pcbi.1003909-Sauro1] and for free energy transduction by molecular motors [@pcbi.1003909-Hill1], [@pcbi.1003909-Liepelt1]. In practice, the values of the individual transition rates can be typically measured *in vitro* but not *in vivo*, and the *in-vitro* rates depend on the composition of the buffer. Because the cytosol represents a rather complex buffer, it is difficult to assess whether a certain *in-vitro* assay provides a reliable description of the process *in vivo*. One important tool that is missing for such an assessment is a simple measure by which we can quantitatively compare the kinetics of a multistep process in different environments.

Here, we develop a general method that provides such a measure and allows the deduction of the *in-vivo* rates from their *in-vitro* values. Our method has two basic components. First, we introduce the 'kinetic distance', i.e., a distance metric for the kinetics, by which we can describe the similarity or dissimilarity of multistep processes *in vitro* and *in vivo* in a quantitative manner. The kinetic distance depends logarithmically on the rates and has an intuitive interpretation in terms of the associated free energy barriers. Second, we minimize the kinetic distance between the *in-vitro* and *in-vivo* processes, imposing the constraint that the deduced rates reproduce a known global property such as the overall *in-vivo* speed. Computationally, this constraint defines a hypersurface in the multi-dimensional space of transition rates. In order to demonstrate the predictive power of our method, we apply it to the elongation cycle of protein synthesis, a key process of gene expression.

In all living cells, proteins are synthesized by ribosomes, which translate the codon sequences of mRNA into peptide chains of proteins. During the elongation cycle of this process, the ribosome translates one codon after another by binding a ternary complex consisting of aminoacyl-tRNA (aa-tRNA), elongation factor Tu (EF-Tu) and GTP. The amino acid is transferred from the tRNA to the nascent peptide chain, and the ribosome moves to the next codon with the help of elongation factor G (EF-G) allowing for the next elongation cycle. Translation elongation involves several individual states with rapid transitions between them [@pcbi.1003909-Wohlgemuth1], [@pcbi.1003909-Voorhees1]. The different states have been studied by a variety of experimental techniques: chemical probing methods [@pcbi.1003909-Moazed1], pre-steady state kinetics [@pcbi.1003909-Dix1]--[@pcbi.1003909-Zaher1], electron microscopy [@pcbi.1003909-Stark1]--[@pcbi.1003909-Agirrezabala1], X-ray crystallography [@pcbi.1003909-Ogle1]--[@pcbi.1003909-Voorhees2], and single molecule methods [@pcbi.1003909-Rosenblum1], [@pcbi.1003909-Johansson2]. The kinetic measurements *in vitro* provided values for the individual transition rates but, so far, it has not been possible to measure the corresponding rates in the cell.

The different states and transitions of the elongation cycle are schematically shown in [Fig. 1](#pcbi-1003909-g001){ref-type="fig"}. When the ribosome dwells at a certain codon and binds a ternary complex, the tRNA within this complex can be cognate, near-cognate, or non-cognate to the codon, which implies that the elongation cycle contains three different reaction pathways corresponding to the three branches in [Fig. 1](#pcbi-1003909-g001){ref-type="fig"}. During each round of elongation, the ribosome typically explores all three pathways in order to select a cognate tRNA and to reject the near-cognate and non-cognate ones. The individual rates of these pathways were measured *in vitro* at 20°C and/or 37°C using the ribosomes and translation factors from *Escherichia coli* [@pcbi.1003909-Wohlgemuth1], [@pcbi.1003909-Johansson1], [@pcbi.1003909-Gromadski2]. Here, we combine these results with new data on the overall elongation rates *in vitro* to first derive a complete set of individual *in-vitro* rates at both temperatures. We then minimize the kinetic distance between the *in-vitro* and *in-vivo* processes, taking into account two known properties of the *in-vivo* process: the overall elongation rates [@pcbi.1003909-Bremer1], [@pcbi.1003909-Liang1] and the tRNA concentrations [@pcbi.1003909-Dong1], both of which have been measured in *E. coli* for different growth conditions.

![Elongation cycle of a ribosome (gray dome) translating an mRNA (black-green-purple line).\
Aminoacyl-tRNA (small gray, green, purple, or orange sphere) is delivered to the ribosome in a ternary complex with the elongation factor EF-Tu (larger blue sphere) and GTP (not shown). In addition to the initial binding site, the ribosome has three tRNA binding sites, the A, P, and E sites. The elongation cycle of translation starts when the A site of the ribosome has arrived at a new codon (green) of the mRNA. The ribosome then binds a ternary complex with a tRNA that may be cognate, near-cognate, or non-cognate to this codon. As a consequence, the elongation cycle exhibits three different branches corresponding to three different reaction pathways: (left) A non-cognate ternary complex is again released from the initial binding site of the ribosome; (top) A near-cognate ternary complex is usually rejected but is very rarely used to elongate the peptide chain; and (bottom) A cognate ternary complex may also be rejected but is typically used for elongation of the peptide chain. The two dotted arrows correspond to additional intermediate states and transitions as explained in more detail in [Fig. 3](#pcbi-1003909-g003){ref-type="fig"} below.](pcbi.1003909.g001){#pcbi-1003909-g001}

The *in-vivo* rates of the elongation cycle obtained in this way are then validated by three independent sets of *in-vivo* data [@pcbi.1003909-Curran1]--[@pcbi.1003909-Kramer1]. First, we compute codon-specific elongation rates and show that these rates correlate well with relative translation rates as obtained experimentally by [@pcbi.1003909-Curran1]. Second, we predict the time-dependent incorporation of radioactively labeled amino acids into proteins as studied *in vivo* by [@pcbi.1003909-Srensen1]. The time course of synthesis obtained theoretically is in excellent agreement with the experimental data. Third, using the same *in-vivo* rates, we also compute the missense error frequency and obtain good agreement with the experimental results of [@pcbi.1003909-Kramer1]. In all three cases, our computations do not involve any fit parameter and, thus, directly validate the derived set of *in-vivo* rates.

Results {#s2}
=======

Distance between *in-vitro* and *in-vivo* kinetics {#s2a}
--------------------------------------------------

In order to introduce a quantitative measure for the (dis)similarity of the *in-vivo* and *in-vitro* kinetics, we consider a generic multistep process within the cell and first focus on one of the individual transitions from state to state . The corresponding transition rates have the values and for a certain *in-vitro* assay and for specific *in-vivo* growth conditions, respectively. Instead of the rates, we can equally well consider the associated transition times and . Thus, we require that the distance between the rates and is equal to the distance between the times and , i.e., that

The *simplest* expression for that fulfills this requirement is provided bywith the logarithmic differencebetween the *in-vitro* and the *in-vivo* value of the individual transition rate.

The single transition distance is dimensionless and does not involve any parameter apart from the two rates and . In addition, this distance satisfies the two scaling relations and for any rescaling factor . The first scaling relation implies that and have the same distance from , which agrees with our intuition. The second scaling relation implies that the distance does not depend on the units used to measure the rates. For small deviations of from , which are equivalent to small deviations of from , the distance becomes asymptotically equal to both and .

The *in-vitro* rate can be expressed in terms of the activation free energy or free energy barrier and the attempt frequency which leads towhere the thermal energy provides the basic free energy scale. When we combine this expression with the analogous expression for the *in-vivo* rate, the logarithmic difference between the two rates becomes

Because the prefactors and are expected to have the same order of magnitude, the second term should usually be small compared to the first term which represents the shift of the free energy barrier between state and state , see [Fig. 2A](#pcbi-1003909-g002){ref-type="fig"}. Therefore, for each individual transition along one of the reaction pathways, the logarithmic difference can be interpreted as the shift of the free energy barrier that governs the transition from state to state . In the following, we will use the intuitive terminology 'single barrier shift' for the quantity . It should be noted, however, that, in spite of this terminology, changes in the attempt frequency as described by the term in Eq. 5 are included in the logarithmic difference and, thus, will be taken into account in all our calculations.

![Kinetic distance based on the logarithmic differences between the *in-vitro* and *in-vivo* rates.\
(A) *In-vitro* free energy barrier and *in-vivo* barrier for the transition from state to state . When expressed in units of , the single barrier shift determines the logarithmic difference , see Eq. 5; and (B) Three-dimensional section of the multi-dimensional barrier space with coordinates , and . The origin of this space (light blue dot) corresponds to the *in-vitro* system. The surface (purple) represents a two-dimensional section of the hypersurface described by Eq. 8, corresponding to a fixed *in-vivo* value for the global kinetic quantity. Each point on this surface has a certain kinetic distance that is equal to the Euclidean distance of this point from the origin, as indicated by the three double arrows. The point with the *shortest* kinetic distance determines the predicted *in-vivo* rates .](pcbi.1003909.g002){#pcbi-1003909-g002}

Next, we consider all individual transitions along the reaction pathways of the multistep process and regard the associated *in-vivo* rates as unknown variables that can be visualized as the coordinates of a multi-dimensional space. These coordinates are somewhat impractical, however, because they are restricted to positive values. In order to eliminate this restriction, we perform a coordinate transformation from the *in-vivo* rates to the single barrier shifts , which can attain both positive and negative values. This coordinate transformation is highly nonlinear but invertible with the inverse transformation given by .

The overall distance between the *in-vitro* and the *in-vivo* kinetics is now defined bywhere the summation under the square root runs over all individual transitions along the reaction pathways. As illustrated in [Fig. 2B](#pcbi-1003909-g002){ref-type="fig"}, the distance represents the Euclidean distance within the multi-dimensional space defined by the single barrier shifts . Therefore, the distance provides a genuine metric in the mathematical sense, which implies that it satisfies the triangle inequality if we compare three different *in-vitro* and/or *in-vivo* conditions.

If all *in-vivo* rates are identical to their *in-vitro* values, apart from a single one, , Eq. 6 for the kinetic distance reduces to Eq. 1 for the single transition distance . Because the choice of the two states and is arbitrary, this property of the kinetic distance applies to all individual transitions that enter in Eq. 6. The latter property represents, in fact, a general requirement for any meaningful definition of the kinetic distance. Therefore, if we considered the more general expression with dimensionless weight factors , this requirement would imply that all weight factors must assume the unique values and that must be equal to the kinetic distance as given by Eq. 6.

If we consider two different *in-vitro* assays, say and , the corresponding transition rates and will, in general, be different and define two sets of single barrier shifts *via* andwith the logarithmic differences . The latter quantities determine the kinetic distance between the two *in-vitro* assays, which is given by . The two sets of barrier shifts, and , provide two different coordinates for the multi-dimensional barrier space. Because of the linear relations as given by Eq. 7, the primed coordinates are obtained from the unprimed ones by shifting the latter coordinates by the logarithmic differences . Therefore, the transformation from the unprimed to the primed coordinates, corresponding to a change from assay A to assay A′, represents a Euclidean translation of the coordinate system, which preserves the shape of any geometric object within the multi-dimensional barrier space.

Constrained minimization of the kinetic distance {#s2b}
------------------------------------------------

Next, we combine the kinetic distance as given by Eq. 6 with a minimization procedure to predict the unknown *in-vivo* rates from their known *in-vitro* values. Even though the rates of the individual transitions are difficult to study in the cell, one can usually measure some quantity that characterizes the overall kinetics of the intracellular process. One such quantity is provided by the average speed of the process. Any such global kinetic quantity, , depends on the individual transition rates, . The *in-vivo* values of the individual transition rates must reproduce the experimentally measured value of the global quantity. This requirement implies the equationwhich represents a constraint on the unknown *in-vivo* values . This constraint can be expressed in terms of the single barrier shifts using the inverse coordinate transformation with the known *in-vitro* values . As a result, the constraint in Eq. 8 defines a hypersurface in the multi-dimensional barrier space as illustrated in [Fig. 2B](#pcbi-1003909-g002){ref-type="fig"}. Each point on this hypersurface is compatible with the measured value of the global kinetic quantity. In addition, the Euclidean distance of such a point from the origin is equal to the kinetic distance between the (unknown) *in-vivo* and the (known) *in-vitro* values of the transition rates. Our prediction for the *in-vivo* values is then obtained by minimizing this kinetic distance, i.e, by the point on the hypersurface that has the *shortest* distance from the origin. For clarity, the coordinate values of this point will be denoted by in order to distinguish these values from the variable coordinates .

Our approach involves the following assumptions. First, we make the usual assumption that the states of the biomolecular system that have been identified *in vitro* are also present *in vivo*. The molecular conformations of the corresponding *in-vitro* and *in-vivo* states are expected to be somewhat different when viewed with atomic resolution, but the gross features of these conformations should be similar, in particular when the *in-vitro* assay is functional and has been optimized. It is then plausible to assume that the *in-vitro* and *in-vivo* values of the individual transition rates do not differ by many orders of magnitude, which implies that the point in the multi-dimensional barrier space that represents the true *in-vivo* rates is located 'in the neighborhood' of the origin of this space and, thus, characterized by a 'small' kinetic distance . If the kinetic distance satisfied , the true *in-vivo* point would be located within a sphere of radius around the origin. The smallest sphere that is compatible with the *in-vivo* constraint as given by Eq. 8 is the one that touches the hypersurface depicted in [Fig. 2B](#pcbi-1003909-g002){ref-type="fig"}, and the radius of this sphere is equal to the Euclidean distance of the hypersurface from the origin of the Δ*~ij~*-coordinates. The associated contact point between -sphere and hypersurface represents the predicted *in-vivo* point, and its coordinate values lead to the predicted *in-vivo* rates based on the known *in-vitro* rates .

For a general, nonlinear *in-vivo* constraint, the coordinate values of the predicted *in-vivo* point will be different for different individual transitions. The minimization procedure then predicts different scale factors and, thus, different effects of the *in-vivo* environment on the individual transitions of the system. Such differences are indeed obtained when we apply our minimization approach to the kinetics of ribosomes as described in the next subsection. It is important to note that this approach leads to different scale factors even though the expression for the kinetic distance (Eq. 6) does not include any bias for one of the individual barrier shifts Therefore, the different scale factors follow from the imposed *in-vivo* constraint (Eq. 8) alone and do not involve any additional assumptions or expectations about the *in-vivo* conditions.

The minimization procedure described above represents an extremum principle with constraints. Such principles have been successfully applied in many areas of science, in particular in the context of optimization problems. One important and useful feature of extremum principles is that they provide *global* solutions for *nonlinear* systems. Thus, in the present context, we would obtain a prediction for the *in-vivo* rates even if the *in-vitro* assay were rather different from the *in-vivo* conditions. Another advantage of extremum principles is that they typically lead to a *unique* solution without any additional assumptions ('principle of least prejudice'). In some exceptional cases, one may find more than one solution, which then indicates that the system undergoes some kind of bifurcation. For the kinetics of ribosomes, see next subsection, we always found a unique solution and, thus, a unique set of predicted *in-vivo* rates.

The rates of the *in-vitro* assay are only known with a certain accuracy. As a consequence, the predicted *in-vivo* rates have some uncertainty as well. As explained in the [*Methods*](#s4){ref-type="sec"} section, this uncertainty reflects both the accuracy of the measured *in-vitro* rates and the associated changes in the location of the predicted *in-vivo* point. Furthermore, the latter location will also depend, in general, on the rates of the chosen *in-vitro* assay. Indeed, the change from assay to assay corresponds to a Euclidean translation of the coordinate system (Eq. 7) while the shape of the hypersurface (Eq. 8 and [Fig. 2B](#pcbi-1003909-g002){ref-type="fig"}) remains unchanged. These two properties imply that the distance of the hypersurface from the origin of the -coordinates may differ from the distance of this surface from the origin of the -coordinates. Therefore, the validity of the predicted *in-vivo* rates is difficult to assess *a priori*, but can be checked *a posteriori* in a self-consistent manner: we first deduce the unknown *in-vivo* rates from the known *in-vitro* rates *via* the minimization procedure and subsequently validate the deduced rates by calculating some other quantities that have been experimentally studied *in vivo*. In the next two subsections, we will apply this two-step procedure to the kinetics of ribosome elongation based on the *in-vitro* assay developed in [@pcbi.1003909-Wohlgemuth1], [@pcbi.1003909-Gromadski2].

Our minimization procedure becomes computationally simpler if we have additional knowledge about some of the *in-vivo* values of the individual transition rates. If we knew one of these rates, e.g., , we would restrict our minimization procedure to the subspace with constant . As a consequence, we would not vary the coordinate during the minimization and use the constant value of this coordinate in Eq. 6 for the kinetic distance . On the other hand, if we knew only that the *in-vivo* rate is located within the range , we would minimize the kinetic distance also with respect to but within the subspace defined by . The latter procedure may lead to a boundary minimum, i.e., to a predicted *in-vivo* point that is located at the boundary of the considered subspace. Another simplification is obtained if the rates of two individual transitions, say from state to state and from state to state , have the same values *in vitro* and *in vivo*, i.e., if and . We will then reduce the multi-dimensional barrier space to the subspace with , and the corresponding expression for the kinetic distance in Eq. 6 will now contain the term under the square root. The latter reduction will be used in the next subsection on the kinetics of ribosomes for which different individual transition rates have the same *in-vitro* values.

Kinetics of ribosomes during protein synthesis {#s2c}
----------------------------------------------

Our quantitative description of the translation elongation cycle is based on the codon-specific Markov process displayed in [Fig. 3](#pcbi-1003909-g003){ref-type="fig"}. This process can visit, for each sense codon , twelve ribosomal states, numbered from 0 to 11. After the ribosome has moved to the next sense codon, it dwells in state 0, until it binds a ternary complex with an elongator tRNA that may be cognate, near-cognate, or non-cognate to codon .

![Codon-specific Markov process for translation elongation based on 12 ribosomal states for each codon .\
The elongation cycle starts in state 0 corresponding to a ribosome without any bound ternary complex. Initial binding of a cognate, near-cognate, or non-cognate ternary complex is indicated by the green, orange, and purple arrow, compare the color code in [Fig. 4](#pcbi-1003909-g004){ref-type="fig"}; the corresponding association rates are proportional to the association rate constant as in Eq. 9. The black arrows represent the individual transitions along the reaction pathways. All ternary complexes dissociate initially with the same dissociation rate . Likewise, cognate and near-cognate ternary complexes are governed by the same recognition rate , conformational rate , and processing rate . The kinetic distinction between the cognate and near-cognate branches arises from initial selection at the states 2 and 7 as well as from proofreading at the states 4 and 9.](pcbi.1003909.g003){#pcbi-1003909-g003}

The genetic code involves 61 sense codons, which encode 20 proteinogenic amino acids and are decoded by a certain number of elongator tRNAs. The latter number depends on the organism but is always larger than 20 and smaller than 61 [@pcbi.1003909-Agris1], [@pcbi.1003909-Grosjean1]. For *E. coli*, 43 distinct species of elongator tRNA have been identified [@pcbi.1003909-Dong1]. The corresponding codon-tRNA relationships can be visualized by the large matrix in [Fig. 4](#pcbi-1003909-g004){ref-type="fig"} with 61 rows and 43 columns. As shown by the color code in this figure, each sense codon defines a *different* decomposition of the total set of tRNA species into three subsets of cognates, near-cognates, and non-cognates. The corresponding molar concentrations , , and of cognate, near-cognate, and non-cognate ternary complexes determine the association ratesfor initial binding with the pseudo-first-order association rate constant . This constant is taken to be independent both of the codon and of the ternary complex as observed *in vitro* [@pcbi.1003909-Rodnina1], [@pcbi.1003909-Gromadski2]. The latter experiments also imply that all ternary complexes dissociate with the same rate from the initial binding site and that the cognate and near-cognate ternary complexes have the same recognition rate .

![Decoding pattern arising from the cognate (green), near-cognate (yellow), and non-cognate (purple) relationships between all 61 sense codons and the 43 elongator tRNA species of *E. coli* as identified in Ref. [@pcbi.1003909-Dong1].\
For each tRNA species, the near-cognate codons differ from the cognate ones by a mismatch in one position of the codon-anticodon complex.](pcbi.1003909.g004){#pcbi-1003909-g004}

After initial binding of a *non-cognate* ternary complex, this complex dissociates without visiting any other state, so that the ribosome returns back to state 0 with an empty initial binding site. Initial binding of a *cognate* ternary complex leads to state 1, from which the ternary complex can be released with rate or can move into the A site to attain the codon recognition state 2 with rate . When the ternary complex is recognized as cognate, the ribosome undergoes a forward transition from state 2 to state 3, which corresponds to the combined process of GTPase activation of the cognate ternary complex and GTP hydrolysis, followed by the irreversible transition from state 3 to state 4, which describes phosphate release and conformational rearrangements of EF-Tu [@pcbi.1003909-Wohlgemuth1]. From state 4, the cognate ternary complex may either move to become fully accommodated into the A site via a transition from state 4 to state 5 or, with low probability, may be released from the A site via a transition from state 4 to state 0. After the cognate ternary complex has been fully accommodated, the ribosome/tRNA complex undergoes the final transition from state 5 into the empty state at the next codon . This transition describes the combined process of peptide bond formation and translocation, the corresponding processing rate is denoted by .

Initial binding of a near-cognate ternary complex leads to state 6, from which the ternary complex can be released with rate or move to the codon recognition state 7 with rate . When the ternary complex is recognized as near-cognate, it is rejected and the ribosome undergoes a backward transition from state 7 to state 6, which provides the initial selection step during the decoding process. With low probability, the near-cognate ternary complex undergoes an irreversible transition from state 7 to state 8, corresponding to GTPase activation and GTP hydrolysis, as well as from state 8 to state 9, which describes phosphate release and conformational rearrangements of EF-Tu. From state 9, the near-cognate ternary complex is typically released again via a transition from state 9 to state 0, which provides the proofreading step during decoding. Very rarely, the near-cognate ternary complex is fully accommodated via a transition from state 9 to state 10. After a near-cognate tRNA has been fully accommodated, it is further processed via peptide bond formation and translocation and undergoes the transition from state 10 to state with rate .

Apart from the association rate constant , the kinetics of the elongation cycle then involves 12 different transition rates for the 17 transitions along the cognate, near-cognate, and non-cognate branches of the Markov process. All of these transition rates have been determined *in vitro* for the high-fidelity buffer developed in [@pcbi.1003909-Gromadski1], [@pcbi.1003909-Gromadski2], [@pcbi.1003909-Wohlgemuth2]. The corresponding *in-vitro* values are reported in [Table 1](#pcbi-1003909-t001){ref-type="table"}. A few individual rates were measured at both 20 and 37°C whereas most of these rates were obtained either at 20 or at 37°C. We used a variety of computational methods to obtain complete and consistent sets of individual rates at both temperatures as described in the [*Methods*](#s4){ref-type="sec"} section. In addition, we measured the overall elongation rate *in vitro* for a model protein, aa/s for 20°C and aa/s for 37°C (Supporting [Figure S1](#pcbi.1003909.s001){ref-type="supplementary-material"}). As explained in the [*Methods*](#s4){ref-type="sec"} section (Eq. 22), the measured value of the overall elongation rate was then used to compute, for both temperatures, the *in-vitro* value of the processing rate. The results of these computations are included in [Table 1](#pcbi-1003909-t001){ref-type="table"}.

10.1371/journal.pcbi.1003909.t001

###### *In-vitro* rates of ribosomal transitions.

![](pcbi.1003909.t001){#pcbi-1003909-t001-1}

  Rates    -not.   20°C   37°C   Units
  ------- ------- ------ ------ -------
                                
                                  1/s
                                  1/s
                                  1/s
                                  1/s
                                  1/s
                                  1/s
                                  1/s
                                  1/s
                                  1/s
                                  1/s
                                  1/s
                                  1/s
                                 aa/s

Apart from the processing rate , all individual rates and the overall elongation rate have been measured *in vitro* at 20°C and/or 37°C. The processing rate was calculated from the overall elongation rate via Eq. 22 in the [*Methods*](#s4){ref-type="sec"} section. The column 'k-not.' provides the notation for the transition rates as used in Ref. [@pcbi.1003909-Wohlgemuth1].

To predict the unknown *in-vivo* rates from the known *in-vitro* rates , we consider the multi-dimensional space of single barrier shifts as described by the coordinates Because several transition rates of the Markov process considered here have the same values ([Fig. 3](#pcbi-1003909-g003){ref-type="fig"}), we use the resulting equalities for the associated coordinates as given by and to reduce the 17-dimensional barrier space to a 12-dimensional subspace and restrict the minimization procedure of the kinetic distance to this subspace. After this reduction, the latter distance has the explicit formwhere the sum contains all the remaining transition rates of the Markov process in [Fig. 3](#pcbi-1003909-g003){ref-type="fig"}.

Because the *in-vivo* experiments are typically performed at 37°C, we use the *in-vitro* values for the same temperature, see [Table 1](#pcbi-1003909-t001){ref-type="table"}. Furthermore, we take into account the known *in-vivo* values of the overall elongation rate at different growth conditions [@pcbi.1003909-Bremer1], [@pcbi.1003909-Liang1]. For each growth condition, the constraint in Eq. 8 now has the explicit form as given by Eq. 23 in the [*Methods*](#s4){ref-type="sec"} section. As a result of the constrained minimization procedure, we find the *in-vivo* rates as given in [Table 2](#pcbi-1003909-t002){ref-type="table"} and the single barrier shifts displayed in [Fig. 5A](#pcbi-1003909-g005){ref-type="fig"}, where we have again omitted the subscript 'min' for notational simplicity.

![Quantitative comparison between the *in-vitro* kinetics of translation elongation at 37°C and the *in-vivo* kinetics as deduced for the growth condition of 2.5 dbl/h.\
(A) Single barrier shifts for the individual transition rates, see Eq. 2 and [Fig. 2](#pcbi-1003909-g002){ref-type="fig"}; and (B) Scale factors for all individual transitions of the ribosomes. A barrier shift implies that the *in-vivo* rate is increased compared to the *in-vitro* rate .](pcbi.1003909.g005){#pcbi-1003909-g005}
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###### *In-vivo* rates of ribosomal transitions.

![](pcbi.1003909.t002){#pcbi-1003909-t002-2}

  Rates    *E. coli* growth rates \[dbl/h\]   RSD    Units               
  ------- ---------------------------------- ------ ------- ------ ----- ------
                          94                   94     94      94    0.1  
                         1400                 1700   2100    2300   0.4   1/s
                         2100                 2500   3000    3300   0.3   1/s
                          2                    2       2      2     0.3   1/s
                         1600                 1600   1700    1700   0.3   1/s
                         490                  500     530    540          1/s
                         270                  300     340    350    0.2   1/s
                          1                    1       1      1           1/s
                         2700                 3100   3900    4300   0.3   1/s
                          5                    5       4      4     0.3   1/s
                         0.27                 0.27   0.27    0.27   0.2   1/s
                          6                    6       6      7     0.2   1/s
                         190                  200     230    230    0.5   1/s
                          15                   18     22      22          aa/s

The values of the overall elongation rate for the four growth conditions 0.7, 1.07, 1.6, and 2.5 dbl/h were obtained from the data in Ref. [@pcbi.1003909-Liang1]. These growth conditions have been chosen because, for these conditions, the total tRNA concentrations have been measured as well in Ref. [@pcbi.1003909-Dong1]. The relative standard deviations (RSDs) in the sixth column were obtained from the errors of the *in-vitro* rates in [Table 1](#pcbi-1003909-t001){ref-type="table"}, and from the associated changes in the predicted in-vivo point, see [*Methods*](#s4){ref-type="sec"} section.

Validation of deduced *in-vivo* rates for translation elongation {#s2d}
----------------------------------------------------------------

Starting from the complete set of individual *in-vivo* rates ([Table 2](#pcbi-1003909-t002){ref-type="table"}), we computed the codon-specific elongation rates as described in the [*Methods*](#s4){ref-type="sec"} section (Eq. 21, Supporting [Figure S3](#pcbi.1003909.s003){ref-type="supplementary-material"}). We then compared the *in-vivo* rates calculated for a growth rate of 2.5 dbl/h to relative translation rates as estimated in Ref. [@pcbi.1003909-Curran1] based on the frequencies of the measured +1 frameshifting vs. readthrough of different codons. As shown in [Fig. 6A](#pcbi-1003909-g006){ref-type="fig"}, we obtain reasonable overall agreement between both data sets with a Pearson correlation coefficient of 0.56. The deviations reflect both limitations of our model parametrization and uncertainties in the experimental method. First, the calculated elongation rates for CGA, CGC, and CGU appear to be overestimated. These codons are all read by tRNA, which does not form a Watson-Crick base pair with any of its cognate codons because it carries inosine at the wobble position of its anticodon ICG. The corresponding reductions in the transition rates are not included in the parametrization of our model because we use only two different sets of values for these rates, corresponding to an average over all cognate and over all near-cognate ternary complexes, respectively. Second, for the experimental setup in [@pcbi.1003909-Curran1], the UUU, UUC, UUG, UCC, and CCC codons, when located between a preceding CUU codon and a subsequent CXX codon, generate potential slippery sequences, which can lead to frameshifting events. The latter events were not considered and, thus, not taken into account by [@pcbi.1003909-Curran1], which implies that the frameshifting rates were underestimated and the translation rates were overestimated for the respective codons. When we exclude these two particular sets of codons, we obtain an increased correlation coefficient of 0.73 as shown in [Fig. 6A](#pcbi-1003909-g006){ref-type="fig"}. Thus, the deduced values of the individual transition rates *in vivo* lead to a reliable description for the majority of codons.

![Comparison with *in-vivo* experiments of translation elongation.\
(A) Codon-specific elongation rates as determined here from the complete set of individual transition rates for *E. coli* at a growth rate of 2.5 dbl/h, see Eq. 21 and Supporting [Figure S3](#pcbi.1003909.s003){ref-type="supplementary-material"}, compared to relative translation rates as measured in Ref. [@pcbi.1003909-Curran1] for 29 codons; highlighted symbols indicate the codons CGA, CGC, and CGU (orange) as well as the codons UUU, UUC, UUG, UCC, and CCC (cyan), see text. The Pearson correlation coefficient is 0.56 for all codons and 0.73 when the highlighted codons are excluded (linear fit in gray). (B) For the incorporation of radioactively labeled amino acids as a function of time, we find very good agreement between the experimental data in Ref. [@pcbi.1003909-Srensen1] and the calculated curve (orange) based on the *in-vivo* rates for 0.7 dbl/h in [Table 2](#pcbi-1003909-t002){ref-type="table"}. For both (A) and (B), our computations do not involve any fit parameter.](pcbi.1003909.g006){#pcbi-1003909-g006}

To further validate these deduced values, we used the computed values of the codon-specific elongation rates (Supporting [Figure S3](#pcbi.1003909.s003){ref-type="supplementary-material"}), to model the time course of protein synthesis measured by [@pcbi.1003909-Srensen1]. In those experiments, the lacZ gene was expressed in *E. coli* at a growth rate of about 0.7 dbl/h, the cells were exposed to a 10-s pulse of radioactively labeled methionine, and the radioactivity of the synthesized proteins was measured over time. The calculated time course is in excellent agreement with the experimental data ([Fig. 6B](#pcbi-1003909-g006){ref-type="fig"}). Furthermore, varying the values of the internal transition rates leads to significant deviations of the simulation curve from the data (Supporting [Figure S4](#pcbi.1003909.s004){ref-type="supplementary-material"}).

Another quantity that can be used to validate the deduced *in-vivo* rates is the missense error frequency arising from the accommodation of near-cognate ternary complexes with incorrect amino acids. The calculated error frequency depends on all individual transitions for the accommodation of a cognate or near-cognate aa-tRNA and, in particular, on the concentrations of cognate and near-cognate ternary complexes whereas it is independent of the concentrations of non-cognates, see Eq. 36 in the [*Methods*](#s4){ref-type="sec"} section. Using the deduced *in-vivo* rates in [Table 2](#pcbi-1003909-t002){ref-type="table"} and the ternary complex concentrations as estimated from the measured tRNA concentrations for 0.7 dbl/h [@pcbi.1003909-Dong1], we obtain an average missense error frequency of for tRNA^Lys^ misreading codons, in good agreement with the measured value [@pcbi.1003909-Kramer1].

Discussion {#s3}
==========

The theoretical approach described here involves two novel concepts. First, we introduced the kinetic distance to provide a quantitative measure for the similarity of the *in-vitro* and *in-vivo* kinetics. This distance has an intuitive interpretation in terms of the free energy barriers that govern the individual transition rates along the reaction pathways, and provides a genuine metric in the mathematical sense. Second, we constructed a constrained minimization procedure in order to deduce the unknown *in-vivo* values of the individual transition rates from their known *in-vitro* values.

It is instructive to compare our approach with flux control or sensitivity analysis, a widely used method for multistep reaction pathways [@pcbi.1003909-Sauro1], [@pcbi.1003909-Kacser1]--[@pcbi.1003909-Fell1], which has also been applied to protein synthesis [@pcbi.1003909-Zouridis1]. The latter method explores the *local* vicinity of a given kinetics and describes the *linear* response of the overall flux to small changes in the individual transition rates in terms of flux control or sensitivity coefficients. In contrast, the theoretical approach introduced here is not restricted to the linear response regime but explores the space of transition rates in a *global* manner via an extremum principle ([Fig. 2B](#pcbi-1003909-g002){ref-type="fig"}). Furthermore, both the coordinate transformation from the individual transition rates to the single barrier shifts and the constraint arising from the global *in-vivo* property make our approach *highly nonlinear*.

When we applied our computational method to translation elongation by ribosomes, we obtained predictions for the individual *in-vivo* rates that could be validated by three independent sets of data for codon-dependent translation speeds, codon-specific translation dynamics and missense error frequencies of protein synthesis. In all cases, we found good agreement between theory and experiment without adjusting any fit parameter.

Even for the largest growth condition of 2.5 dbl/h, most of the deduced *in-vivo* rates are similar to the measured *in-vitro* rates ([Fig. 5B](#pcbi-1003909-g005){ref-type="fig"}) but three *in-vivo* rates are significantly increased compared to their *in-vitro* values: the rejection rate for near-cognates, the dissociation rate after initial binding, and the recognition rate for cognate and near-cognate ternary complexes. The largest difference is found for the rejection rate , which is increased *in vivo* by a factor of 3.9, while the dissociation rate and the recognition rate are increased by a factor 3.3 and 2.2, respectively.

For all transition rates of the elongation cycle, we find that the deviations between the *in-vivo* and *in-vitro* rates correspond to relatively small shifts of the corresponding free energy barriers ([Fig. 5A](#pcbi-1003909-g005){ref-type="fig"}). In fact, all single barrier shifts are predicted to be smaller than . Because the cytosol represents a rather complex buffer, such small changes in the free energy barriers can be easily envisaged, arising, e.g., from changes in the hydrogen bond networks around the ribosome or from changes in the flexibility of some parts of this complex. On the other hand, our results also show that the high-fidelity buffer at 37°C, used here and developed by [@pcbi.1003909-Gromadski2] represents a good approximation to the cytosol as far as the ribosomal kinetics is concerned, in contrast to earlier estimates in Ref. [@pcbi.1003909-Johansson3].

The free energy barriers considered here could be studied by Molecular Dynamics simulations. The latter method has been recently applied to explore the free energy landscape of tRNA translocation through the ribosome [@pcbi.1003909-Whitford1], [@pcbi.1003909-Bock1]. From such simulations, one can estimate the attempt frequencies for barrier crossing which are difficult to determine by other computational methods. In principle, these simulation techniques could also be used to investigate how the energy landscape changes as one varies the ambient buffer conditions in the simulations.

Even though the predicted shifts of the free energy barriers are relatively small, the associated changes of the transition rates have an interesting consequence for the relative importance of initial selection and proofreading for the error frequency of protein synthesis. For the codon-specific Markov process depicted in [Fig. 3](#pcbi-1003909-g003){ref-type="fig"}, the efficiency of initial selection and proofreading are described by the coefficients and , respectively. The *in-vivo* value of the initial selection coefficient is increased by a factor of 7.7 compared to the corresponding *in-vitro* value whereas the proofreading coefficient is increased by a factor of 2.9. The combination of improved initial selection and proofreading leads to a reduction of the *in-vivo* error frequency by a factor of 6.7, a reduction that is primarily achieved by the improved initial selection of the bound ternary complexes.

In the present study, the codon-dependence of the elongation cycle arose from the initial binding rates that depend on the concentrations of cognate, near-cognate, and non-cognate tRNA, because we used the same transition rates along the reaction pathways for all cognate as well as for all near-cognate tRNAs. Thus, the values of the rates , , ...of the cognate branch represent average values, obtained by averaging over all cognate tRNAs of all codons, and likewise for the internal rates , , ...of the near-cognate branch. *In vitro*, the decoding rates of different cognate codons were observed to be rather similar [@pcbi.1003909-Ledoux1], [@pcbi.1003909-Gromadski2] whereas the GTPase activation rate was found to vary between 0.06/s and 1.3/s for different near-cognate codons of tRNA [@pcbi.1003909-Gromadski2]. Likewise, recent *in-vivo* experiments provided evidence that the error frequency on 4 out of 14 near-cognate codons of tRNA is much higher than on the remaining 10 near-cognate codons [@pcbi.1003909-Manickam1]. Theoretically, it is straightforward to include codon-specific decoding and processing rates. Experimentally, it is, however, quite challenging to determine these rates *in vitro* for all codons and tRNA species.

Our theory for protein synthesis by ribosomes can be extended in a variety of ways. For example, one could study how the overall elongation rate or the missense error frequency vary with changes in the overall ternary complex composition or as a function of individual ternary complex concentrations. Likewise, one may investigate how changes in internal transition rates arising, e.g., from protein or rRNA mutagenesis, affect the speed and accuracy of translation elongation.

The computational method developed here to deduce the *in-vivo* from the *in-vitro* rates is relatively simple and can be applied, in general, to any multistep process or Markov model, for which one can estimate the *in-vitro* rates. Simple examples are provided by the folding and unfolding of proteins, the catalytic activity of enzymes with one active site, or the motility of molecular motors. More complex examples are transcription by RNA polymerase, protein refolding by chaperones, or protein degradation by proteases. Our method can also be applied to the large number of biochemical processes that have been studied by flux control or sensitivity analysis. Furthermore, the similarity measure provided by the kinetic distance could be useful in the context of systems biology, where the importance of detailed kinetics has been recently emphasized [@pcbi.1003909-Tummler1]. One important target in systems biology is to standardize the experimental data for such networks. Using the kinetic distance introduced here, one could, in fact, compare the kinetic data obtained by different groups in a systematic and quantitative manner.

Methods {#s4}
=======

Codon-specific accommodation times {#s4a}
----------------------------------

Using the general theory of stochastic processes [@pcbi.1003909-Norris1], [@pcbi.1003909-Taylor1], we derived explicit expressions for important dynamical quantities of the translation elongation cycle ([Fig. 3](#pcbi-1003909-g003){ref-type="fig"}) in terms of the individual transition rates. These quantities include the codon-specific accommodation times, i.e., the times that the ribosome needs to fully accommodate a cognate or near-cognate tRNA and, thus, to move from state 0 to state 5 or state 10 for the Markov process in [Fig. 3](#pcbi-1003909-g003){ref-type="fig"}. A straightforward but somewhat tedious computation leads to explicit, analytical expressions for these time scales in terms of the individual transition rates . These expressions can be decomposed into four different dwell times according toa decomposition that directly reflects the state space of the Markov process in [Fig. 3](#pcbi-1003909-g003){ref-type="fig"} and has the following intuitive interpretation.

The first dwell time represents the total time that the ribosome spends in state 0 during one complete elongation cycle at codon . Because of the different dissociation and backward transitions, the ribosome typically visits the state 0 several times before it is fully accommodated in the states 5 or 10, see [Fig. 3](#pcbi-1003909-g003){ref-type="fig"}. The second dwell time in Eq. 11 corresponds to the total time that the ribosome binds a non-cognate ternary complex and, thus, dwells in state 11 during one complete elongation cycle at codon . The third dwell time corresponds to the total time that the ribosome spends in the intermediate states 1, 2, 3, and 4 of the cognate branch during one complete elongation cycle at codon . Finally, the fourth dwell time in Eq. 11 represents the total time that the ribosome spends in the intermediate states 6, 7, 8, and 9 of the near-cognate branch.

These four dwell times can be expressed in a particularly compact and transparent manner if one uses the transition probabilities

The dwell time , which the ribosome spends in state 0 during one complete elongation cycle at codon , then has the formand, thus, depends on the concentrations and of free cognate and near-cognate ternary complexes as well as on the dimensionless, concentration-independent ratiosand

The second dwell time for state 11 with a bound non-cognate ternary complex is given by the expressionand is, thus, proportional to the concentration of free non-cognate ternary complexes.

The third dwell time , which represents the sum of all dwell times for the intermediate states 1, 2, 3, and 4 of the cognate branch, can be written aswith the concentration-independent time scalethat depends only on transitions that emanate from the intermediate states of the cognate branch. Likewise, the fourth dwell time for the intermediate states 6, 7, 8, and 9 of the non-cognate branch has the formwith the concentration-independent time scalethat depends only on transitions that emanate from the intermediate states of the near-cognate branch.

Codon-specific and overall elongation rates {#s4b}
-------------------------------------------

The expression for the codon-specific accommodation time as given by Eq. 11 involves all individual rates apart from the processing rate . When we add the processing time , we obtain the codon-specific elongation time which the ribosome needs to complete a full elongation cycle at a certain codon . The codon-specific elongation rates are then given by

One important global property of protein synthesis is the average speed of the ribosomes, which defines the overall elongation rate . The inverse of the overall elongation rate is equal to the average elongation time , which is obtained by averaging the codon-specific elongation times over all codons using the codon usage . For each codon , the quantity represents the probability that the ribosome encounters this codon. These probabilities are normalized and satisfy .

For the *in-vitro* assay, the relation between the overall elongation rate and the codon-specific accommodation times was rewritten in the formand then used to calculate the processing rate from the measured value of the overall elongation rate and the measured values of the individual rates , which determine the codon-specific accommodation times .

*In vivo*, the overall elongation rate is given by the analogous expressionwhere the codon-specific accommodation times follow from the same expression as in Eq. 11 but with the *in-vitro* values replaced by the *in-vivo* values . When we insert the known *in-vivo* value of the overall elongation rate into Eq. 23, we obtain a constraint on the (unknown) *in-vivo* values of the individual transition rates. This constraint can be expressed in terms of the single barrier shifts when we replace in Eq. 23 by , see Eq. 2.

*In-vitro* values of individual transition rates {#s4c}
------------------------------------------------

All *in-vitro* values of the individual transition rates as given in [Table 1](#pcbi-1003909-t001){ref-type="table"} have been obtained for the high-fidelity buffer as developed in [@pcbi.1003909-Gromadski1], [@pcbi.1003909-Gromadski2], and [@pcbi.1003909-Wohlgemuth2]. Most of these values are based on previous measurements as explained in the following paragraph. In addition, we also performed new experiments to measure the overall elongation rate , both at 20°C and at 37°C, see Supporting [Figure S1](#pcbi.1003909.s001){ref-type="supplementary-material"}, as well as the individual rates and at 20°C, see Supporting [Figure S2](#pcbi.1003909.s002){ref-type="supplementary-material"}, using the experimental protocols described previously [@pcbi.1003909-Wohlgemuth2], [@pcbi.1003909-Mittelstaet1], [@pcbi.1003909-Doerfel1].

The *in-vitro* value of the association rate constant was previously measured at 20°C [@pcbi.1003909-Gromadski1]. Its value at 37°C was obtained assuming an Arrhenius temperature dependence and using the previously determined activation energy of 2.4 kcal/mol for initial binding [@pcbi.1003909-Rodnina1]. The dissociation rate at 20°C was taken from [@pcbi.1003909-Gromadski1]. The decoding rates at 20°C were obtained by averaging over previously published values as measured for different codons of tRNA. In particular, we averaged the rates as given in [Table 1](#pcbi-1003909-t001){ref-type="table"} of [@pcbi.1003909-Gromadski2] for cognate as well as for near-cognate codons to obtain the rates , , , , and . The rate has not been measured but estimated under the assumption that it is not rate-limiting. The rate at 37°C was reported previously and was used to determine the rate , i.e., using an error frequency of 0.06 for the proofreading step [@pcbi.1003909-Wohlgemuth2]. The rate has been measured both for 20°C and for 37°C [@pcbi.1003909-Gromadski2], [@pcbi.1003909-Wohlgemuth2]. The rate was calculated for both temperatures from the measured values of the overall elongation rate via Eq. 22.

Finally, we assumed an Arrhenius temperature dependence to estimate some of the *in-vitro* rates at 37°C from their values as measured at 20°C. These estimates are based on the following considerations. We start from Eq. 4 for the transition rates and use the decomposition of the activation free energy into the activation enthalpy and the activation entropy , which leads towhere the last expression involves the attempt frequency as obtained from transition-state theory [@pcbi.1003909-CornishBowden1]. In this way, any state-dependence of the attempt frequency has been absorbed into the activation entropies . If one plots the logarithms of the measured rates as a function of the inverse temperature (conventional Arrhenius plots), one finds linear relationships [@pcbi.1003909-Rodnina1], [@pcbi.1003909-Johansson1], [@pcbi.1003909-Sievers1], [@pcbi.1003909-Kuhlenkoetter1], which imply that the two unknown parameters in Eq. 24, and , do not depend on temperature over the experimentally studied temperature range. However, the activation entropies as obtained from the behavior of for small vary significantly with the ribosomal states and [@pcbi.1003909-Rodnina1], [@pcbi.1003909-Johansson1], [@pcbi.1003909-Sievers1], [@pcbi.1003909-Kuhlenkoetter1]. Possible molecular mechanisms for this variation have been recently discussed based on atomistic molecular dynamics simulations [@pcbi.1003909-Whitford2].

Using the expression in Eq. 24 with -independent enthalpies and entropies , we now consider the ratios at the two temperatures of interest, K and K. We take the accommodation rate as a reference rate because the value of this rate has been measured at both temperatures. For each individual transition, we then obtain two equations, corresponding to the two temperatures and , which can be combined to eliminate the enthalpy . As a result, we obtain the relation

At present, the entropy differences are difficult to estimate for all individual transitions from the available experimental data. However, these differences are multiplied by the relative temperature difference which is rather small. Therefore, we used the approximate relationto estimate the values of the rates , , , , , , , and at 37°C ([Table 1](#pcbi-1003909-t001){ref-type="table"}) from the measured values of , , and .

*In-vivo* values of association rates {#s4d}
-------------------------------------

The overall elongation rate as given by Eq. 23 also depends on the association rates for initial binding, which are proportional to the pseudo-first-order rate constant and to the concentrations of the ternary complexes as in Eq. 9. Therefore, in order to use Eq. 23 for the process *in vivo*, we had to estimate the corresponding values and the ternary complex concentrations in the cell.

The diffusion of ternary complexes and, thus, their binding to ribosomes is slowed down *in vivo* by molecular crowding. The time it takes a ternary complex to find a single ribosome depends on the cell volume, the diffusion constant of the ternary complex, and the ribosome size [@pcbi.1003909-Condamin1]. Using the diffusion constant of /s [@pcbi.1003909-Elowitz1], [@pcbi.1003909-Fluitt1] for a ternary complex in the cytosol, we found that the *in-vivo* value of the bimolecular association rate constant is about 54% of the *in-vitro* value , compare [Table 1](#pcbi-1003909-t001){ref-type="table"} and [Table 2](#pcbi-1003909-t002){ref-type="table"}.

For the *in-vivo* concentrations of the ternary complexes, we used the values of the tRNA concentrations as measured by [@pcbi.1003909-Dong1] in *E. coli* for the growth conditions of 0.7, 1.07, 1.6, and 2.5 dbl/h. In the latter study, the authors determined the concentrations of all 43 elongator tRNA species . These concentrations are then combined, for each codon , into the concentrations , , and of cognate, near-cognate, and non-cognate ternary complexes within the cell. Thus, for each codon , we started from the corresponding row in [Fig. 4](#pcbi-1003909-g004){ref-type="fig"}, and added all concentrations up that correspond to green (cognate), yellow (near-cognate), and purple (non-cognate) tRNA species, respectively.

Uncertainty of predicted *in-vivo* rates {#s4e}
----------------------------------------

To estimate the uncertainty of the predicted *in-vivo* rates , we first simplify the notation. In this section, the internal transitions with distinct transition rates will be distinguished by the subscript with . Thus, we now use the short-hand notation , , and for the *in-vitro* rates of a certain assay, for the unknown *in-vivo* rates , and for the predicted *in-vivo* rates , respectively. For ribosome elongation as described by the Markov process in [Fig. 3](#pcbi-1003909-g003){ref-type="fig"}, we distinguish internal transitions.

The inaccuracy or error of the *in-vitro* rates can be described bywith the absolute error and the relative errorof the *in-vitro* rate . Both the average values and the absolute errors are estimated from the experimental data for the *in-vitro* assay under consideration.

When we apply the minimization procedure to the average values of the *in-vitro* rates, we use the coordinatesfor the multi-dimensional barrier space. We then determine the point that is located on the hypersurface defined by Eq. 8 and depicted in [Fig. 2B](#pcbi-1003909-g002){ref-type="fig"} and has the shortest distance from the origin of the -coordinates. The coordinate values of the point then lead to the predicted values for the *in-vivo* rates.

In order to estimate the uncertainty of these predictions, it is useful to consider an auxiliary ensemble of fictitious *in-vitro* assays that is constructed 'around' the given assay as follows. For each transition , we introduce the binary variable . The binary variables can assume different 'configurations' as described by the different -tuples

Each of these configurations defines a fictitious *in-vitro* assay, again denoted by , with transition rates

The rates of assay define the coordinatesfor the multi-dimensional barrier space withwhere the asymptotic equality applies to the limit of small relative errors of the *in-vitro* rates. Therefore, if the origin of the multi-dimensional barrier space is defined by the coordinates in Eq. 29, corresponding to the average *in-vitro* rates , the ensemble of the fictitious assays forms the corners of a multi-dimensional 'error polyhedron' around this origin. For each corner, again labeled by , we can apply our minimization procedure and minimize the kinetic distance of the point from the hypersurface as defined by Eq. 8 and depicted in [Fig. 2B](#pcbi-1003909-g002){ref-type="fig"}. The point on the hypersurface with the shortest distance from the corner has the coordinates .

The variations in the coordinate values of the predicted *in-vivo* point as obtained for different corners can be used to obtain an estimate for the absolute error of these coordinate values. We then write the coordinate values of the predicted *in-vivo* point in the formwhere the values correspond to the average *in-vitro* rates . The predicted *in-vivo* rates are now given by

Therefore the relative error of the predicted *in-vivo* rates reflects both the relative error of the *in-vitro* rates (Eq. 27) and the absolute error of the coordinate values for the predicted *in-vivo* point (Eq. 34).

The Markov process for ribosome elongation considered here, see [Fig. 3](#pcbi-1003909-g003){ref-type="fig"}, involves distinct transition rates, which implies that the corresponding barrier space has 12 dimensions. We first determined the coordinate values of the *in-vivo* point as predicted from the average value of the *in-vitro* rates. The largest coordinate values of the predicted *in-vivo* point were found for the three transition rates , , and ([Fig. 5B](#pcbi-1003909-g005){ref-type="fig"}). We then focused on the errors of these three *in-vitro* rates, which define 8 corners of the 'error polyhedron' around the origin of the -coordinates. For each of these corners , we determined the closest point on the hypersurface and the coordinate values of this point. We then estimated the absolute error of the coordinate values from the largest and smallest values of as obtained for different corners . The errors were finally used, together with the relative errors of the measured *in-vitro* rates, to determine the relative standard deviations (RSDs) of the predicted *in-vivo* rates as displayed in [Table 2](#pcbi-1003909-t002){ref-type="table"}.

Missense error frequency {#s4f}
------------------------

Consider a certain tRNA species and a codon that is near-cognate to . The missense error frequency for misreading the codon by the tRNA species is equal to the probability that is fully accommodated at . For the multistep process considered here, this probability is given bywhich depends on the concentration of the near-cognate ternary complex species , on the concentrations and of all cognate and near-cognate ternary complexes as well as on the concentration-independent ratios and as given by Eqs. 14 and 15.

The experimental study in [@pcbi.1003909-Kramer1] determined the error frequency for all codons that are near-cognate to . The average error frequency for misreading one of these codons is then obtained fromwhere the set contains all codons that are near-cognate to and denotes the codon usage as before.

Supporting Information {#s5}
======================

###### 

**Overall elongation rate as measured for a model protein** ***in vitro***. Kinetics of CspA translation *in vitro* at different temperatures. CspA mRNA, which codes for a 70 aa-long protein from *E. coli*, was prepared by T7 RNA-polymerase transcription. Ribosomes were synchronized by forming an initiation complex consisting of 70S ribosomes, CspA mRNA and a fluorescence derivative of initiator tRNA^fMet^ carrying BodipyFL at the *α*-amino group of Met in the presence of initiation factors (IF1, IF2, and IF3) and GTP. Translation was carried out in a fully reconstituted translation system by adding initiation complexes (15 nM) to a mixture of EF-Tu--GTP--aminoacyl-tRNA (40 µM aminoacyl-tRNA, 100 µM EF-Tu in total), EF-G (3 µM), GTP (2 mM), phosphoenol pyruvate (6 mM), and pyruvate kinase (0.1 mg/ml) in HiFi buffer (50 mM Tris-HCl, pH 7.5, 30 mM KCl, 70 mM NH~4~Cl, 3.5 mM free MgCl~2~, 0.5 mM spermidine, and 8 mM putrescine) at the indicated temperatures [@pcbi.1003909-Mittelstaet1]. In the absence of translation termination and ribosome recycling factors, translation was limited to a single round, i.e. at most one molecule of CspA was synthesized per ribosome. The reactions were stopped at the indicated time intervals and translation products separated on 16.5% Tris-Tricine-PAGE and visualized by the fluorescent reporter BODIPY-Fl at the N-terminus of the peptides [@pcbi.1003909-Doerfel1] (left panels). The intensity of the full length product was quantified with ImageJ (right panel, circles). Average translation rates per codon, which depend on the elongation rates only, were determined by exponential fitting (fits in graphs of the right panel).

(TIF)

###### 

Click here for additional data file.

###### 

***In-vitro*** **rates as measured for near-cognate accommodation and rejection after proofreading.** *In-vitro* values of the rates and for near-cognate accommodation and rejection after proofreading at 20°C as determined by the experimental protocol described previously in Ref. [@pcbi.1003909-Wohlgemuth2]. The formation of f\[^3^H\]Met\[^14^C\]Phe was monitored under multiple-turnover conditions using initiation complexes 70S--mRNA(AUGCUC)--f\[^3^H\]Met-tRNA^fMet^ (0.14 μM) and varying concentrations of the ternary complex EF-Tu--GTP--\[^14^C\]Phe-tRNA^Phe^, which is near-cognate to the CUC codon. For each concentration of the ternary complex, the rates were determined from the linear slopes of the time courses. From the hyperbolic dependence of the concentration dependence of , we calculated s and Using the previously measured efficiency of the proofreading step [@pcbi.1003909-Gromadski2], we then obtained the value s for near-cognate rejection after proofreading.

(TIF)

###### 

Click here for additional data file.

###### 

**Codon-specific elongation rates** ***in vitro*** **and** ***in vivo*** **.** Codon-specific elongation rates in units of amino acids per second as calculated from Eq. 17, see [*Methods*](#s4){ref-type="sec"} section in the main text, using the decomposition of the codon-specific elongation times in Eq. 7 and the complete sets of individual transition rates: (A) *In-vitro* values for the high-fidelity buffer at 37°C, obtained from the individual rates in [Table 1](#pcbi-1003909-t001){ref-type="table"}; (B, C) *In-vivo* values for *E. coli* at growth conditions of (B) 0.7 dbl/h and (C) 2.5 dbl/h, calculated from the individual rates in [Table 2](#pcbi-1003909-t002){ref-type="table"}.

(TIF)

###### 

Click here for additional data file.

###### 

**Incorporation of radioactively labeled amino acids for different dissociation rates.** Experimental data (black stars) for the incorporation of radioactively labeled amino acids at a growth rate of 0.7 dbl/h [@pcbi.1003909-Srensen1] and simulation curves obtained for five different values of the initial dissociation rate . The orange simulation curve in the middle corresponds to s, see [Table 2](#pcbi-1003909-t002){ref-type="table"}. This value has been obtained from the minimization of the kinetic distance and provides an excellent fit to the data. The red, blue, green, and black curves have been obtained for simulations with , , , and , respectively. Thus, changing the value of by 20% leads to a significant deviation of the simulation curve from the experimental data.

(TIF)

###### 

Click here for additional data file.
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